Literature DB >> 15838520

SCF-mediated protein degradation and cell cycle control.

Xiaolu L Ang1, J Wade Harper.   

Abstract

The regulatory step in ubiquitin (Ub)-mediated protein degradation involves recognition and selection of the target substrate by an E3 Ub-ligase. E3 Ub-ligases evoke sophisticated mechanisms to regulate their activity temporally and spatially, including multiple post-translational modifications, combinatorial E3 Ub-ligase pathways, and subcellular localization. The phosphodegrons of many substrates incorporate the activities of multiple kinases, and ubiquitination only occurs when all necessary phosphorylation signals have been incorporated. In this manner, the precise timing of degradation can be controlled. Another way that the Ub pathway tightly controls the timing of proteolysis is with multiple E3 Ub-ligases acting upon a single target. Lastly, subcellular localization can either promote or prevent degradation by regulating the accessibility of kinases and E3 Ub-ligases. This review highlights recent findings that exemplify these emerging themes in the regulation of E3 Ub-ligase substrate recognition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15838520     DOI: 10.1038/sj.onc.1208614

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  67 in total

1.  A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal components.

Authors:  Carlos Gorbea; Gregory Pratt; Vicença Ustrell; Russell Bell; Sudhir Sahasrabudhe; Robert E Hughes; Martin Rechsteiner
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

2.  Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism.

Authors:  Ryan J Davis; Mehmet Gönen; Daciana H Margineantu; Shlomo Handeli; Jherek Swanger; Pia Hoellerbauer; Patrick J Paddison; Haiwei Gu; Daniel Raftery; Jonathan E Grim; David M Hockenbery; Adam A Margolin; Bruce E Clurman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

3.  FBXO25-associated nuclear domains: a novel subnuclear structure.

Authors:  Adriana O Manfiolli; Ana Leticia G C Maragno; Munira M A Baqui; Sami Yokoo; Felipe R Teixeira; Eduardo B Oliveira; Marcelo D Gomes
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

Review 4.  Turning off the G2 DNA damage checkpoint.

Authors:  Teresa M Calonge; Matthew J O'Connell
Journal:  DNA Repair (Amst)       Date:  2007-09-11

5.  Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells.

Authors:  Rita Crinelli; Marzia Bianchi; Michele Menotta; Elisa Carloni; Elisa Giacomini; Marzia Pennati; Mauro Magnani
Journal:  Mol Cell Biochem       Date:  2008-07-09       Impact factor: 3.396

Review 6.  Regulating DNA replication in eukarya.

Authors:  Khalid Siddiqui; Kin Fan On; John F X Diffley
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

7.  Brd4 regulation of papillomavirus protein E2 stability.

Authors:  Gang Zheng; Michal-Ruth Schweiger; Gustavo Martinez-Noel; Leon Zheng; Jennifer A Smith; J Wade Harper; Peter M Howley
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

8.  Abnormal retinal development in the Btrc null mouse.

Authors:  Mark Baguma-Nibasheka; Boris Kablar
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

9.  HERC2 targets the iron regulator FBXL5 for degradation and modulates iron metabolism.

Authors:  Toshiro Moroishi; Takayoshi Yamauchi; Masaaki Nishiyama; Keiichi I Nakayama
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

10.  Mutant p53 disrupts the stress MAPK activation circuit induced by ASK1-dependent stabilization of Daxx.

Authors:  Tetsuya Kitamura; Yayoi Fukuyo; Masahiro Inoue; Nobuko T Horikoshi; Masanobu Shindoh; Buck E Rogers; Anny Usheva; Nobuo Horikoshi
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.